Nifuratel

DB13724InvestigationalSmall molecule

Nifuratel is a nitrofuran derivative indicated in the treatment of leucorrhea, vulvovaginal infections, and urinary tract infections. A medication used to treat vaginal infections and discharge, as well as urinary tract infections.

Mechanism: Pharmacologically active on Signal transducer and activator of transcription 3
Curator reviewed
Formula / weight: C₁₀H₁₁N₃O₅S · 285.27 g/mol (avg)

Resolves to

Compound

UNIIU60U6P08SPCAS4936-47-4ChEMBLCHEMBL514315ChEBI135180

Clinical / RWD

RxNorm7419ATCG01AX05

Structure

InChIKeySRQKTCXJCCHINN-NYYWCZLTSA-NSMILESCSCC1CN(\N=C\C2=CC=C(O2)[N+]([O-])=O)C(=O)O1

Targets

P40763STAT3

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

14Drug interactionsStructured to mechanism, not free text

6Structured indicationsCondition, population, route and combination as fields, not prose

1ContraindicationEach with its own population and attribute set

19Marketed productsAcross 4 countries and 8 labellers

1ATC codeIncluding every combination product, plus 12 drug categories

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Nifuratel, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Log In Paid Account Log In